SALT LAKE CITY, Sept. 22, 2009 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present an overview of the Company at The Fourth Annual JMP Securities Healthcare Focus Conference, at 9:00 a.m. Eastern on October 5, 2009, at the New York Palace Hotel in New York City.
